Allgens Medical Technology Stock Net Asset
| 688613 Stock | 17.15 0.16 0.94% |
Allgens Medical Technology fundamentals help investors to digest information that contributes to Allgens Medical's financial success or failures. It also enables traders to predict the movement of Allgens Stock. The fundamental analysis module provides a way to measure Allgens Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allgens Medical stock.
Allgens | Net Asset |
Allgens Medical Technology Company Net Asset Analysis
Allgens Medical's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Current Allgens Medical Net Asset | 1.53 B |
Most of Allgens Medical's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allgens Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Allgens Total Assets
Total Assets |
|
Based on the recorded statements, Allgens Medical Technology has a Net Asset of 1.53 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net asset for all China stocks is notably lower than that of the firm.
Allgens Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allgens Medical's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allgens Medical could also be used in its relative valuation, which is a method of valuing Allgens Medical by comparing valuation metrics of similar companies.Allgens Medical is currently under evaluation in net asset category among its peers.
Allgens Fundamentals
| Return On Equity | 3.0E-4 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 135.55 M | ||||
| Shares Owned By Insiders | 42.74 % | ||||
| Shares Owned By Institutions | 2.38 % | ||||
| Price To Book | 1.62 X | ||||
| Price To Sales | 12.16 X | ||||
| Revenue | 226.48 M | ||||
| Gross Profit | 204.53 M | ||||
| EBITDA | (12.88 M) | ||||
| Net Income | 54.23 M | ||||
| Total Debt | 5.07 M | ||||
| Book Value Per Share | 10.49 X | ||||
| Cash Flow From Operations | 51.68 M | ||||
| Earnings Per Share | 0.04 X | ||||
| Number Of Employees | 202 | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 2.32 B | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 275.99 M | ||||
| Working Capital | 1.15 B | ||||
| Annual Yield | 0 % | ||||
| Net Asset | 1.53 B | ||||
| Last Dividend Paid | 0.06 |
About Allgens Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Allgens Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allgens Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allgens Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.